Innovative Pharmaceutical Biotech (HK:0399) has released an update.
Innovative Pharmaceutical Biotech Limited has scheduled a board meeting for June 28, 2024, to review and approve the company’s annual consolidated results for the year ended March 31, 2024. The announcement was made by Executive Director Tang Rong, confirming the company’s ongoing efforts to assess its financial performance and strategic direction. This could be a significant event for shareholders and investors seeking to understand the company’s current position and future outlook.
For further insights into HK:0399 stock, check out TipRanks’ Stock Analysis page.
